Clinical Updates

U.S. health regulators have approved a new Johnson & Johnson drug for patients with tuberculosis who do not respond to… »   

A mercury-containing preservative should not be banned as an ingredient in vaccines, U.S. pediatricians said Monday, in a move that… »   

A mercury-containing preservative should not be banned as an ingredient in vaccines, U.S. pediatricians said Monday, in a move that… »   

German drugmaker Bayer said on Friday it requested approval from U.S. regulators for an experimental prostate cancer drug that could… »   

The approved use of the drug Zytiga has been expanded to include treatment of men with late-stage, hormone therapy-resistant prostate… »   

India has revoked a patent granted to an asthma drug made by Schering Corp, later bought by U.S.-based Merck &… »   

A new drug for patients with acute myeloid leukemia (AML) marked by a specific type of genetic mutation has shown… »   

A new class of drugs reduced the risk of patients contracting a serious and often deadly side effect of lifesaving… »   

Baxter International Inc said on Tuesday it would buy privately held Swedish kidney dialysis product company Gambro AB for about… »   

GlaxoSmithKline expects to have pivotal clinical trial results on up to 14 medicines in the next two years, including two… »   

Whitehead Institute scientists report that certain molecules present in high concentrations on the surfaces of many cancer cells could be… »   

KUALA LUMPUR: The Health Ministry assured the public that Ranbaxy products were safe from possible glass particle contamination.

Its deputy… »   

Generic manufacturers are to be given a free rein to make cheap copies of Johnson & Johnson’s HIV/AIDS drug Prezista… »   

Ranbaxy Laboratories Ltd, India’s top drugmaker by sales, said it has launched Absorica, a drug used to treat recalcitrant acne,… »   

U.S. states should remain the primary regulators for compounding pharmacies, rather than the U.S. Food and Drug Administration, despite a… »